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From the Midwestern Vascular Surgical Society
Vascular and endovascular surgeon: The vascular
specialist for the 21st century and beyond
Peter Gloviczki, MD, Rochester, MinnI would like to thank the society for the honor and
privilege of being your 28th president. Nothing is more
humbling than recognition by one’s peers, so I am most
grateful for the distinction and proud to serve this distin-
guished organization.
THE MIDWESTERN VASCULAR
SURGICAL SOCIETY
This society has a rich tradition in academic vascular
surgery, and our annual meetings and postgraduate courses
have always defined the latest standards in surgical and,
more recently, in endovascular treatment of vascular disease.
As one of the most distinguished regional vascular surgery
societies, we provide a forum for scientific and social inter-
change between our members located in 12 states of a large
and prominent geographic region of the United States,
which includes 32 medical schools and 24 approved vascu-
lar surgery fellowships (Fig 1).
The list of our past presidents includes giants of our
profession (Table I), and I am delighted to have here so
many previous presidents, including the founding president
of the Midwestern Vascular Surgery Society, first editor of
the Journal of Vascular Surgery, the 95-years-young D.
Emerick Szilagyi, from Detroit, Michigan.
Our society, founded in 1976 by our first three presi-
dents, among others, has a great history. And no society has
a better archivist than Jack Pfeiffer. For each annual meet-
ing, he magically delivers a new edition of a special program
book of the Midwestern Vascular Surgical Society. Our
society is likely the only one which presents to every mem-
ber such a beautifully printed hard-cover history book1 of
the organization, coauthored by Pfeiffer and past president
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412John W. Hallett, together with a book on the two promi-
nent vascular surgery pioneer researchers, Nobel Prize–
winner Alexis Carrel and Charles Guthrie.2 I also would like
to give credit to another surgeon, who has worked for our
society for countless years and has produced the best Web
site any regional society has ever had—Dr Joe Schneider.
I am pleased to report to you that under the leadership
of an experienced and committed executive council, our
society has grown tremendously during the past year. With
the addition of a candidate group and an associate member
group to our membership categories, tomorrow at the
business meeting our members will vote on the approval of
57 new members, thereby increasing our society member-
ship for the first time to more than 500 members (Fig 1).
As you witnessed this morning, this year for the first
time, in addition to the Guthrie Award that is given for the
best paper in basic research, we established the D. Emerick
Szilagyi Award for the best paper in clinical research to
honor our first president.
Abstract submissions this year increased by 40%, and
our program committee, headed by Secretary Walter Mc-
Carthy, selected an excellent program from 58 submitted
abstracts. To increase attendance at our endovascular
course, this year the course was incorporated into our
regular meeting. Treasurer Brian Rubin, from St. Louis,
invited an outstanding faculty for the course. For the
organization of a first-rate annual meeting and for helping
our society during the entire year, our gratitude should go
to Terri Rojas and her organization, BostonBased, for a
great performance. Finally, no meeting today is possible
without the support of our colleagues in the medical indus-
try, and we are pleased to acknowledge the educational
grants offered to our society by so many companies.
PERSONAL REFLECTIONS
A presidential address is a unique opportunity to honor
those who have contributed most to our professional de-
velopment. I owe the most to my parents—my father
Zoltan and my mother Eva. My father was a great role
model to me, both as a family man and as a physician. It is
interesting that he graduated from the same medical school
in the city of Debrecen, Hungary, where my other role
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grated to the United States in 1931.
I would also like to acknowledge here the support of
my own family, especially my children, Julia and Peter. I
never thought I would learn from them, but I did. From
Julia, a junior at the University of Vermont, Burlington,
who is a talented and avid equestrian, I learned courage and
persistence and that hurdles in our way are merely chal-
lenges. From my son, Peter, who is majoring in political
science at St. Olaf College, and who at age 21 already has
his first book listed on Amazon.com and is executive editor
of the college newspaper, theManitouMessenger, I learned,
among other things, the wisdom of how to write this
presidential address. His advice was to the point, “Dad, it is
easy. What you have to do is sit down and start writing.”
I learned vascular surgery from Professor Lajos Soltesz
at Semmelweis Medical School in Budapest, Hungary. He
taught me that vascular surgeons should provide both
medical and surgical care to their patients and that vascular
diseases include not only arterial but also venous and lym-
Fig 1. Data of the Midwestern Vascular Surgery Society with map
of participating states.
Table I. Past presidents of the Midwestern Vascular
Surgery Society (1977-2004)
D. Emerick Szilagyi Malcolm B. Herring
John J. Bergan Richard F. Kempczinski
James C. Stanley William R. Flinn
John J. Cranley, Jr Bruce L. Gewertz
David S. Sumner John W. Hallett, Jr
William E. Evans Howard P. Greisler
William H. Baker William D. Turnipseed
Donald Silver Gregario A. Sicard
James S. T. Yao Walter M. Whitehouse,
Norman R. Hertzer Patrick J. O’Hara
Larry H. Hollier Gerald B. Zelenock
John Glover B. Timothy Baxter
Jonathan B. Towne John D. Corson
Fred Littooyphatic diseases, so we should deal with them all.During a fellowship year that I spent in Paris in the mid
70s, I worked with Professors M. Servelle and J.M. Cormier
and also with Dr Pierre Lagneau. The French school, based
on the work of giants like Fontaine, Leriche, Dubost,
Oudot, and Thevenet, made tremendous contributions to
vascular surgery and is largely responsible for the develop-
ment of vascular surgery as a surgical specialty. I was also
impressed by the work of Professor Natalie and noticed the
work of a talented young surgeon in his department whose
name was Eduard Kieffer.
It was 25 winters ago that I moved to Rochester,
Minnesota, where I learned right away that those cold, long
winters in Budapest were actually not cold and not long at
all. My first mentor in Rochester was Larry Hollier, an
outstanding vascular surgeon and the 11th president of this
society. I was Larry’s first research fellow in Rochester, and
later he helped me when I joined the staff of Mayo Clinic.
He left Rochester soon after that, but we kept in contact
and remained friends. I saw him recently on national tele-
vision during the tragic events caused by Hurricane Kat-
rina; as dean of LSU Medical School, he reported on the
tremendous losses to their research facilities in New Or-
leans.
During the past 25 years, I have had the privilege to
work with several other outstanding surgeons at Mayo
Clinic. Many of them were my mentors who became col-
leagues and then close friends—Drs Pairolero, Cherry,
Hallett, and Bower (Fig 2, A). I cherish very much the
friendship with my current partners, Tom Bower, Manju
Kalra, Geza Mozes, Audra Noel, and Tim Sullivan (Fig 2, B).
I owe much of my experience to them.
Being surrounded by young people—our residents and
fellows, eager to learn vascular surgery—gives me great
satisfaction. I know exactly why Dr William J. Mayo once
said, “Each day as I go through the hospitals surrounded
by younger men, they give me of their dreams and I give
them of my experience, and I get the better of the
exchange.” I am most thankful to the 58 vascular surgery
fellows (Table II) I have had a chance to train during the
past 18 years, and I am pleased that many of them are here
today. Without their hard work and their dreams to one day
become the best vascular surgeon ever, I would not stand at
this podium today.
THE FUTURE OF VASCULAR SURGERY
The topic I selected for this presidential address deals
with our specialty and with us: vascular and endovascular
surgeons. Many things I will mention today have been said
before in presidential addresses, editorials, and newsletters.
Still, for the sake of the future of our specialty, they have to
be said again and again. We have to know—our colleagues,
our patients, and the American public have to know—who
are the vascular surgeons and where are they going? As
Oscar Wilde once said, “The past is of no importance. The
present is of no importance. It is with the future that we
have to deal.”
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endovascular revolution has made to our specialty and
recent developments in the training of vascular and endo-
vascular surgeons. I also would like to discuss with you the
role of the vascular centers and bring up the important issue
of the inter-relationship and future of all vascular specialists.
THE CHANGING FACE
OF VASCULAR SURGERY
Members of this society know it better than anyone
else: vascular surgery is rapidly changing. The endovascular
revolution transformed both arterial and venous surgery for
both acute and chronic disease. The list of options we offer
as treatment to our patients start with catheters, balloons,
and stents, followed by short incisions and stent-grafts, and
only later do we talk to them about open surgical repair.
Endovascular surgery is becoming the first line of treatment
of vascular disease and vascular injuries in almost every part
of the body. Endovenous procedures, laser, or radiofre-
quency treatment of the saphenous vein, to a large extent
replaced classic operations such as high ligation and saphe-
nous stripping. Acute iliofemoral deep vein thrombosis is
preferentially treated by catheter-directed thrombolysis and
percutaneous mechanical thrombectomy but not open sur-
Fig 2. A, Members of the Division of Vascular Surgery, Mayo
Clinic, (standing) and fellows (sitting) in 1989. B, Division of
Vascular Surgery, Mayo Clinic, 2005.gical thrombectomy. Finally, stents are preferred for iliacvein or inferior vena cava occlusions over surgical bypass,
which is reserved today for those who are not candidates for
stents or who failed endovascular management.
I have always considered myself a traditional Mayo
Clinic vascular surgeon, and I don’t mind if some of my
colleagues call me conservative. I always place the patient’s
interest ahead of experimenting with new technology;
however, I give the patient a chance to make the final
decision on his or her treatment. Patients today are knowl-
edgeable and well informed. They have access to the Inter-
net, MEDLINE, surgical or interventional journals, and to
the latest data on new technology. Patients have the right
and the freedom to select less-proven but minimally inva-
sive, cutting-edge technology, with fewer immediate risks,
even if conventional open surgery is more established and
obviously more durable. The need for repeat interventions
because of early failure appears to be less of a problem for
many patients than previously thought, as long as the
procedure poses minimal risk.
Although I find much joy and great satisfaction in open
vascular surgery, I took seriously what Frank Veith told us
just about a decade ago: “Become endocompetent or be-
come extinct.”3 My association with two vascular surgery
publications rapidly resulted in changing the names of
both. Approval by the visionary editorial boards was imme-
diate. These two journals, Perspectives in Vascular Surgery
and Endovascular Therapy andVascular and Endovascular
Surgery, reflect the changing face of our profession; they
also serve the practitioners of our specialty, the vascular and
endovascular surgeons. The name may sound redundant to
some, but you heard what Dr Szilagyi mentioned this
morning: endovascular surgery is not what he would call
vascular surgery.
There is no doubt that some open procedures are per-
formed much less frequently today than they were even 2 years
ago. Open aortoiliac or aortofemoral bypasses have become
rarities, and at the same time the number of implanted iliac
artery stents has increased rapidly (Fig 3, A and B).
Open renal artery reconstructions won’t be done often
enough anymore in most training programs to teach it to
young vascular surgeons, who may at any rate prefer placing
renal artery stents over performing high-risk endarterecto-
mies or renal artery bypasses. Consequently, the number of
renal artery stent placements has rapidly increased in recent
years at our institution, as well as in others (Fig 4, A and B).
Although we are just starting with placement of carotid
stents, their numbers will double this year compared with
last year, and without doubt, many of the carotid proce-
dures will soon be placement of carotid stents. The percent-
age of endovascular abdominal aortic aneurysm (AAA)
repair procedures has increased at our institution, and in
2004, 44% of AAAs were repaired with endografts (Fig 5.)
Although endovascular surgery is here to stay and it will
be practiced more frequently than open surgery, there is
ample evidence to suggest that we should not just throw
our knives away. Open vascular surgeons are still needed in
almost all areas of traditional surgery, even in the most
rapidly transforming field of AAAs. This is supported by
Reed
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randomized multicenter studies. The British clinical trial
EVAR 1 found no survival difference at 4 years between
open and endovascular repair of AAAs.4 The EVAR 2 trial
found no advantage of stent-grafts over observation in
high-risk patients who underwent endovascular aneurysm
repair,5 and the smaller Dutch DREAM trial also failed to
find survival difference at 2 years between those who un-
derwent endovascular treatment and those who had open
surgical repair.6 In addition, it will be another 4 years, when
the PIVOTAL study is completed, until we find out whether
endovascular repair is justified in patients with small AAAs.
Even enthusiastic proponents of endovascular therapy
admit that 6 years from now there will still be plenty of open
vascular surgery (Table III).7 These predictions correspond
with findings of independent national research organiza-
tions that predict that in 2009, 30% of the peripheral
Fig 3. A, Annual numbers of aortoiliac and aortofemo
occlusive disease between 1999 and 2004. B, Annual nu
2001 and 2004.
Table II. Vascular Surgery Fellows, Mayo Clinic, 1987-20
C. Daniel Procter Robert
James L. McCullough Yvonne
Martha M. Reigel Jean M
David Calcagno Robert
Thomas C. Bower John P.
Joseph T. Crepps John R
Seth W. Wolk William
Russell G. Bourchier Christo
Steven A. Hutchinson Steven
John P. Pigott Sunil S.
James R. Elmore John A
Steven W. Merrell Matthe
Christopher F. Roland Jae-Sun
R. Thomas Bergman P. Mich
Matthew J. Dougherty Kevin L
Erich S. Berens Jeffrey
Robert C. Lowell David C
C. Phifer Nicholson Audra A
Christian M. DeVirgilio Jeffrey
Amy B.vascular procedures will still be done by open vascularsurgery.8 This appears believable, with the increasing age of
the population and the findings that many endovascular
procedures performed for infrainguinal occlusive disease
likely delay but do not eliminate the need for open surgical
bypasses.
TRAINING OF VASCULAR AND
ENDOVASCULAR SURGEONS
Vascular surgery training must be changed with the
idea that the specialist we train will be both a vascular and
an endovascular surgeon. When we attract medical students
and general surgery residents, we should think of both open
surgical and endovascular training. Retraining open vascular
surgeons by offering them endovascular training must be the
priority of every regional and national society. We should
welcome and participate in postgraduate courses offered by
the Society for Vascular Surgery or any other regional or
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the past decade was tremendously advanced by the exis-
tence of the American Board of Vascular Surgery and its
Fig 4. A, Annual numbers of open surgical reconstructions of
renal arteries performed at Mayo Clinic between 1983 and 2004.
B, Annual numbers of percutaneous transluminal renal angioplas-
ties and renal artery stent placements performed between 1993 and
2004.
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Fig 5. Annual numbers of open and endovascular repair of ab-
dominal aortic aneurysms (EVAR). Values indicate EVAR as a
percentage of all repairs.efforts to establish an independent board for vascular sur-geons. There is ample evidence in Europe that vascular
surgery is a surgical specialty, separate from general surgery.
I received my first vascular surgery board certificate in
Budapest, Hungary, in 1980 from the Hungarian Board of
Vascular Surgery.
During the past year, the Vascular Surgery Board
(VSB) of the American Board of Surgery (ABS) reported a
major and successful change in the training of vascular
surgery residents. Largely to reflect the need for endovas-
cular training, in March 2005 the American Board of
Medical Specialties approved a primary certificate in vascu-
lar surgery. Further approval by the Residency Review
Committee and the Accreditation Council for Graduate
Medical Education can be expected in the next 6 months,
and the primary certificate will go into effect in July 2006.
Former president of the MVSS, Jonathan Towne, MD,
who chairs the VSB-ABS, believes that it is a formal recog-
nition of vascular surgery as a distinct specialty. For the first
time, medical students and residents who select vascular
surgery as their specialty can undergo 3 years of general
surgery and 3 years of vascular and endovascular surgery
training without the need to obtain a general surgery board
Table III. Proportions of vascular lesions that will be
treated by open surgery in the United States in 2009*
Vascular lesions %
AAA 20-35
Ruptured AAA 20-35
Carotid bifurcation stenosis 35-55
Aortoiliac occlusive disease 10-20
Supraaortic trunks 10-20
Thoracic aneurysms 25-40
Renal artery stenosis 10-20
Visceral disease 30-40
Infrainguinal disease 30-50
Trauma 30-40
AAA, Abdominal aortic aneurysm
*From: Veith FJ. Metamorphosis of vascular surgeons to endovascular
specialists: must vascular surgery have an independent board and can we get
there? Vascular 2005;13:197-201 (with permission).
Table IV. Potential benefits of multidisciplinary vascular
centers
● Patient and disease centered (the needs of the patient come
first)
● Includes all specialties who deal with non-cardiac vascular dis-
ease
● Highest level of care independent of entry
● Benefits of expertise of other vascular specialties
● Avoids duplication of resources (space, equipment, staff)
● Integrated clinical practice based on common credentialing
and re-credentialing guidelines, and common quality control
● Integrated training of endovascular specialists, integrated vas-
cular conferences
● Integrated research, common database
● Integrated hospital servicecertificate.
JOURNAL OF VASCULAR SURGERY
Volume 43, Number 2 Gloviczki 417VASCULAR SPECIALISTS
Although the primary certificate is progress, the fight
for an independent board of vascular surgery is not over yet.
The idea of a new American Board of Vascular Specialists
was raised recently, accepting the reality that other vascular
specialists also treat patients with vascular disease, and that,
on at least the endovascular front, we may have more in
common with them than with other surgical specialists.7
This issue needs much discussion and further scrutiny, and
the primary certificate, as proposed by chief peacemaker
and past president of the Society for Vascular Surgery,
Fig 6. Blueprint and data of the Mayo Clinic Gonda Vascular
Center. Examination, diagnostic and procedure rooms are located
in the center and surrounded by 21 physician offices.Fig 7. Clinical programs of the MayoGregory Sicard, deserves a good chance, but there is ample
proof that collaboration at some levels with these specialties
can be mutually beneficial. Examples include the success of
the multidisciplinary American Venous Forum, joint cre-
dentialing documents, the soon-to-be-published joint
guidelines for management of peripheral arterial disease
(PAD), the success of public education by a truly multidis-
ciplinary Vascular Disease Foundation,9 or the PAD coali-
tion campaign, just recently funded by the National Heart,
Lung, and Blood Institute.10
VASCULAR CENTERS
Vascular specialists work well together in settings
such as some form of vascular center. Much has been said
about the advantages and disadvantages of such cen-
ters,11-15 and more recently, the model in which the
vascular center is run exclusively by one specialty has
gained more popularity.12 Different levels of centers,
staffed mainly by vascular surgeons, were presented re-
cently in the presidential address of the Society for
Clinical Vascular Surgery by Enrico Ascher, who also
proposed credentialing of level 1 and 2 vascular cen-
ters.12 Our almost two decades of experience with the
Mayo Clinic Gonda Vascular Center suggests that mul-
tidisciplinary vascular centers can be beneficial for the
patients and the stakeholders alike. Although far from
being without turf issues between competing specialists,
our success is backed up by the positive experience of our
sister Gonda Center at UCLA and by recent Europe-
an efforts to set up multidisciplinary vascular centers
throughout Europe.16
Although local policies, institutions, and practices are
different and many vascular surgery practices at large insti-
tutions have been successful without much collaboration
with other specialties, the number of joint ventures is visiblyClinic Gonda Vascular Center.
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president of our society, Dr Turnipseed, earlier at this
meeting; we heard the Wisconsin model on the benefits of
collaboration between vascular surgeons and interventional
cardiologists. I truly believe that more of this will follow, for
obvious reasons.
Potential benefits of a multidisciplinary vascular center
are listed in Table IV. The most significant part of this
concept is that it is patient and disease centered, with the
goal to provide the highest level of care to each patient,
independent of the site of entry into the hospital or clinic
system. Integrated training and credentialing and inte-
grated quality control of the endovascular specialists help to
maintain the same standard of care, independent of the
Fig 8. Growth of relative value-units, examinations, an
Gonda Vascular Center between 1999 and 2004.
Fig 9. Growth of outpatient volume at Gonda Vascular Center
between 1997 and 2004.participating departments. Hospitals welcome collabora-tions between surgeons and cardiologists or interventional
radiologists just to avoid duplication of facilities, expensive
equipment, and human resources. Integrated databases and
research permit rapid accumulation of a large amount of
data on new, cutting-edge endovascular therapy, an appar-
ent advantage in today’s rapidly changing technology.
MAYO CLINIC GONDA VASCULAR CENTER
The history, the provided services, and the early orga-
nization structure of the multidisciplinary Gonda Vascular
Center in Rochester, Minnesota, was discussed by Hallett
et al.11 The success of multidisciplinary treatment of pa-
t volumes and total clinical full-time employees at the
Fig 10. Forecast of percutaneous endovascular peripheral arterial
procedures at Mayo Clinic up to 2007. An increase of 74% in the
next 3 years is a conservative estimate.d testients with venous disease in the center concept was also
e of v
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cular therapy and the emergence of the three separate
specialties—vascular surgery, vascular medicine, and inter-
ventional cardiology—in addition to interventional radiol-
ogy, which expressed desire and legitimate need to partic-
ipate in an integrated endovascular program, resulted both
in changes in the leadership structure (interventional cardi-
ology was included in the executive committee) and in
substantial institutional support to develop an integrated
endovascular strategic plan. These changes are well in line
with the mission of Mayo Clinic, which long has followed
the belief that “The best interest of the patient is the only
interest to be considered.” Many parts of the strategic plan
that is currently finalized by all stakeholders are already in
Fig 11. The futur
Fig 12. National forecast of peripheral arterial procedur
Services. Strategic Forecast and Investment Blueprint. T
with permission).effect and used in the endovascular care of our patients.Much of the success of the center is attributed to the
excellent physical facility that brings together, in a clinic
space of 32,000 square feet, 35 vascular specialists and 65
allied health staff (Fig 6). The proximity of 26 examination
rooms to 18 vascular laboratory rooms makes possible the
efficient evaluation of a large number of patients in the short-
est time. Still, one of the most important aspects is the
proximity of physicians’ offices, and surgeons have imme-
diate access to diagnostic or interventional radiologists or
have a chance to discuss patient management with nine
vascular medicine physicians. Integrated weekly vascular
center grand rounds have been in place for more than two
decades.
Since 2002, the Gonda Vascular Center has functioned
ascular specialists.
mes between 2004 and 2009. (From: Future of Vascular
visory Board Company, Washington D.C. 2004. p. 92,e volu
he Adas a campus-wide independent multidisciplinary program.
l, end
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center with the primary goals of coordinated, comprehen-
sive, and multidisciplinary evaluation. Similar in aims and
structure to the transplant center, the vascular center has a
leadership, budget, staff, and strategic plan that is indepen-
dent of the parent departments. Run currently by a surgeon
director and an executive committee that includes leaders
of the main participating specialties (vascular medicine,
diagnostic and interventional radiology, interventional car-
diology, and vascular surgery), the center also includes
physicians from general internal medicine, dermatology,
podiatry, physical medicine and rehabilitation, cardiology,
hypertension, hematology, orthopedic surgery, and plastic
surgery. With 12 different outpatient vascular programs, in
addition to the endovascular program and in-patient hos-
pital services (Fig 7), the vascular surgery group alone could
not possibly provide the expertise needed in a level 1
vascular center. It is the multispecialty collaboration that
permitted us to increase our activities substantially in recent
years (Fig 8) and triple the number of outpatient visits from
somewhat more than 10,700 visits in 1997 to more than
30,000 patients in 2004 (Fig 9).
THE FUTURE OF VASCULAR SPECIALISTS
Endovascular technology will progress by leaps and
bounds, and we estimate the number of percutaneous
endovascular procedures in our center to double in the next
4 years (Fig 10). We also have to realize, as we were
reminded by Richard Green in his presidential address,18
that we are not the sole participants in this endovascular
revolution. National forecasts for vascular operators in
2009 predict a share of 40% by interventional radiologists,
the same by vascular surgeons, and 20% by cardiologists.8 If
I have to predict, I will count four groups because vascular
medicine soon will be a factor in vascular interventions. As
said by past president of this society Larry Hollier 12 years
ago, “Our policy cannot be one to attempt to block or in
any way inhibit the desire of other specialties to manage
Fig 13. Participation of vascular specialists in medicavascular patients.”19 Time spent for training, high-qualityperformance, healthy competition, and access to patients
will determine who eventually will succeed. Clearly, four
groups will form the new breed of vascular specialists. A
core group of these, but not all, will be endovascular
specialists (Fig 11).
National forecasts of peripheral arterial procedures also
indicate that because of earlier treatment of PAD and the
advancing age of the population, the number of peripheral
arterial procedures will increase in 5 years by 25% (Fig 12).
Most of it, a 40% increase, will be due to percutaneous
vascular procedures. Still, 4% growth is forecasted for open
procedures.8 Thus, there will always be a need for vascular
surgeons who perform open vascular procedures.
Vascular specialists deal with medical, endovascular,
and surgical treatment of vascular disease (Fig 13). Al-
though vascular medicine physicians will largely focus on
medical therapy, they will also participate in endovascular
interventions. Interventional cardiologists will attempt to
embrace both medical and endovascular treatment, and
interventional (vascular) radiology will focus more on en-
dovascular therapy, but to stay alive and be competitive,
they must be present at the outpatient clinic and run a
hospital service as well. They must turn into clinicians and
must gain access to patients to survive as a specialty. The
only specialty, however, that can and will embrace all three
areas—medical, endovascular, and surgical therapy—is vas-
cular and endovascular surgery. Vascular and endovascular
surgeons will maintain leadership in the field of vascular
diseases. They are the vascular specialists of the 21st century
and beyond. I am grateful to the society for the distinct
privilege of the presidency, and I thank you again for the
opportunity to serve this great society.
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